Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07033169 · ClinicalTrials.gov registry record
A Skin Image Reference Tool to Aid Healthcare Providers' Diagnosis
A clinical trial of Dermatologic Disease, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT07033169 is a study of Dermatologic Disease that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 400 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07033169, a study of Dermatologic Disease, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
Consented patients will have three images taken of their dermatologic conditions within the Belle.ai software. These images will be uploaded and saved within the Belle software system where a single AI-generated differential list will be generated based on the three photos. All photos uploaded will be de-identified. The software will not have any unique identifiers of participants saved in the system. The photos will be named based on participant enrollment numbers or unique code numbers and no unique identifiers will be attached to the photos. There will be no data collection form necessary for this study
Conditions Studied
Study Locations (1)
North Carolina
- Wake Forest University Health Sciences Department of Dermatology - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2025-09-15 |
| Est. Completion | 2027-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07033169
The ClinicalTrials.gov registry entry for NCT07033169 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Dermatologic Disease appearing as the primary indexed condition, and to 0 interventions.
NCT07033169 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT07033169 about?
NCT07033169 is a clinical study titled "A Skin Image Reference Tool to Aid Healthcare Providers' Diagnosis". Consented patients will have three images taken of their dermatologic conditions within the Belle.ai software. These images will be uploaded and saved within the Belle software system where a single AI-generated differential list will be generated based on the three photos. All photos uploaded will ...
What is the current status of trial NCT07033169?
This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2025-09-15. Estimated completion is 2027-12.
What conditions does trial NCT07033169 study?
This clinical trial studies the following conditions: Dermatologic Disease.
Who is sponsoring clinical trial NCT07033169?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07033169 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dermatologic Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.